A study to evaluate whether a drug, levetiracetam decreases pain after laparoscopic gall bladder surgery.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- ASA grade I and II who are posted for elective laparoscopic cholecystectomy
- Registration Number
- CTRI/2013/12/004255
- Lead Sponsor
- azareth Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
ASA I and II, scheduled for elective laparoscopic cholecystectomy
Exclusion Criteria
1. Patients with known sensitivity to Levetiracetam or Iron tablet.
2. Patients who do not give consent to be enrolled in the study.
3. Patient who has seizure disorder
4. history of chronic pain
5. pregnant or breast feeding females
6. Uncontrolled medical disease ( diabetes mellitus and hypertension)
7. impaired kidney or liver function
8. body mass index (BMI) < 19 and >35 kg/m2
9. unable to understand pain score
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method